| Literature DB >> 10440017 |
D Aarsland1, J P Larsen, N G Lim, E Tandberg.
Abstract
Twenty-one patients with Parkinson's disease and psychosis were included in an open-label 8-week trial of olanzapine. Eight subjects had dementia. Six subjects (29%) discontinued treatment prematurely because of drowsiness. Delusions and hallucinations improved significantly, and 80% were rated as much or very much improved. There was no worsening of parkinsonism or cognition.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10440017 DOI： 10.1176/jnp.11.3.392
Source DB: PubMed Journal: J Neuropsychiatry Clin Neurosci ISSN： 0895-0172 Impact factor: 2.198